Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001-2023.

GHB-related death rates increased from 2016, accompanied by changes in case characteristics. In recent years GHB use appears to have extended to a population more likely to have substance use problems and use other respiratory depressants.